The functional differences between autistic and non-autistic brains have been isolated for the first time, following the development of a new methodology for analysing MRI scans. Developed by researchers at the University of Warwick, the methodology, called Brain-Wide Association Analysis (BWAS), is the first capable of creating panoramic views of the whole brain and provides scientists with an accurate 3D model to study.
The New big data methodology can analyse over 1 billion pieces of data. The methodology can potentially isolate the areas of the brain involved with other cognitive problems, including Obsessive Compulsive Disorder, ADHD and schizophrenia. The opensource study is published in the journal Brain.
The researchers used BWAS to identify regions of the brain that may make a major contribution to the symptoms of autism. BWAS does so by analysing 1,134,570,430 individual pieces of data; covering the 47,636 different areas of the brain, called voxels, which comprise a functional MRI (fMRI) scan and the connections between them. Previous methodologies which processed this level of data were restricted to modelling only limited areas.
In the current study the ability to analyse the entire data set from an fMRI scan provided the researchers the opportunity to compile, compare and contrast accurate computer models for both autistic and non-autistic brains. The researchers collected the data from hundreds of fMRI scans of autistic and non-autistic brains. By comparing the two subsequent models the researchers isolated twenty examples of difference, where the connections between voxels of the autistic brain were stronger or weaker than the non-autistic .
The team identified differences which included key systems involved with brain functions relating to autism. They identified a key system in the temporal lobe visual cortex with reduced cortical functional connectivity. This region is involved with the face expression processing involved in social behaviour. This key system has reduced functional connectivity with the ventromedial prefrontal cortex, which is implicated in emotion and social communication.
The current study also identified a second key system relating to reduced cortical functional connectivity, a part of the parietal lobe implicated in spatial functions.
The researchers propose that these two types of functionality, face expression-related, and of one’s self and the environment, are important components of the computations involved in theory of mind, whether of oneself or of others, and that reduced connectivity within and between these regions may make a major contribution to the symptoms of autism.
By using meta-analysis and a rigorous statistics approach the researchers were able to collect and use a big data set to obtain significant results, the likes of which have not been seen in autistic literature before. The group used BWAS to analyse resting state fMRI data collected from 523 autistic people and 452 controls. The amount of data analysed helped to achieve the sufficient statistical power necessary for this first voxel-based, comparison of whole autistic and non-autistic brains. Until the development of BWAS this had not been possible.
The team surmise that BWAS tests for differences between patients and controls in the connectivity of every pair of voxels at a whole brain level. Unlike previous seed-based or independent components-based approaches, this method has the great advantage of being fully unbiased in that the connectivity of all brain voxels can be compared, not just selected brain regions.
The team states that the methodology can potentially isolate the areas of the brain involved with other cognitive problems, including Obsessive Compulsive Disorder, ADHD and schizophrenia.
Source: University of Warwick
autism, big data, brain connections, brain map, Brain-Wide Association Analysis, fMRI, functional magnetic resonance imaging, healthinnovations, imaging, magnetic resonance imaging, MRI, neurobiology, neuroimaging, neuroinnovations, opensource
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.